|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
RED CELLS
From the Institute of Medical Biochemistry, Division of
Molecular Biology and Institute of Molecular Pathology, Vienna
Biocenter; Dr Bohr-Gasse, Vienna, Austria; Department of Pathology and
Laboratory Medicine, University of Pennsylvania, Philadelphia; and Lady
Davis Institute for Medical Research, Jewish General Hospital, and the
Departments of Physiology and Medicine, McGill University, Montreal,
Quebec, Canada.
In primary chicken erythroblasts (stem cell factor [SCF]
erythroblasts), transferrin receptor (TfR) messenger RNA (mRNA) and protein were hyperexpressed as compared to nonerythroid chicken cell
types. This erythroid-specific hyperexpression was abolished in
transformed erythroblasts (HD3E22 cells) expressing the
v-ErbA and v-ErbB oncogenes of avian
erythroblastosis virus. TfR expression in HD3E22 cells could be
modulated by changes in exogenous iron supply, whereas expression in
SCF erythroblasts was not subject to iron regulation. Measurements of
TfR mRNA half-life indicated that hyperexpression in SCF erythroblasts
was due to a massive stabilization of transcripts even in the presence
of high iron levels. Changes in mRNA binding activity of iron
regulatory protein 1 (IRP1), the primary regulator of TfR mRNA
stability in these cells, correlated well with TfR mRNA expression;
IRP1 activity in HD3E22 cells and other nonerythroid cell types tested
was iron dependent, whereas IRP1 activity in primary SCF erythroblasts could not be modulated by iron administration. Analysis of avian erythroblasts expressing v-ErbA alone indicated that
v-ErbA was responsible for these transformation-specific
alterations in the regulation of iron metabolism. In SCF erythroblasts
high amounts of TfR were detected on the plasma membrane, but a large
fraction was also located in early and late endosomal compartments,
potentially concealing temporary iron stores from the IRP regulatory
system. In contrast, TfR was almost exclusively located to the
plasma membrane in HD3E22 cells. In summary, stabilization of TfR mRNA and redistribution of Fe-Tf/TfR complexes to late endosomal
compartments may contribute to TfR hyperexpression in primary
erythroblasts, effects that are lost on leukemic transformation.
(Blood. 2002;100:289-298) All proliferating cells need iron but also
have to cope with the extreme toxicity of free iron, which participates
in redox reactions leading to radical formation. Therefore, iron
metabolism has to be kept under tight surveillance.1,2
This is especially true for erythroblasts with their increased demand
for iron during terminal differentiation.
Vertebrate cells take up iron from iron-loaded diferric serum
transferrin (Tf), which is internalized via transferrin receptors (TfRs) by receptor-mediated endocytosis. Inside the cell, the low pH in
acidic endosomes liberates iron from Tf for cellular use or storage in
ferritin (Fer). (Apo)-Tf/TfR complexes return to the cell
surface for reutilization.3 In most cell types, coordinate
regulation of TfR and Fer expression maintains iron homeostasis.2,4 Cis-acting palindromic
elements, termed iron responsive elements (IREs), and transacting
factors, the iron regulatory proteins (IRP) IRP1 and IRP2, mediate this
process. When iron is scarce, IRPs bind to IREs in the 3'
untranslated region (UTR) of TfR messenger RNA (mRNA), increasing its
stability. IRP binding to the IRE in the 5'UTR of Fer mRNA decreases
translation initiation. This leads to increased iron uptake via TfR and
less capacity for iron storage in Fer.5-7 Conversely, high
iron levels induce rapid TfR mRNA degradation and allow efficient Fer
protein synthesis, inhibiting iron uptake and favoring storage.
This type of regulation will be referred to here as the "standard"
model of iron homeostasis. IREs have also been identified in several other mRNAs, including the erythroid isoform of Most studies addressing regulation of erythroid iron metabolism have
been performed with established cell lines derived from leukemias10 or with spontaneously immortalized
cells.11 All these cell types require no or nonphysiologic
stimuli for proliferation and differentiation and usually fail to
mature terminally as well as to express the correct pattern of
erythroid proteins.12,13 To overcome these drawbacks, we
used primary erythroblasts grown out from chicken bone marrow in the
presence of the self-renewal factors stem cell factor (SCF),
transforming growth factor Our analyses focused on TfR expression and regulation by IRP1 in
primary self-renewing erythroblasts compared with transformed erythroid
cells and cells of nonerythroid origin. In particular, we used (1)
primary SCF erythroblasts after 4 days of outgrowth from chicken bone
marrow in the presence of self-renewal factors17; (2)
erythroblasts stably transfected with a retroviral vector expressing
the SCF receptor, c-Kit19 (these strictly factor-dependent cells undergo extended self-renewal in media containing Epo, SCF, and
Dex for about 30 divisions before senescence); (3) immortalized HD3E22
erythroblasts, transformed by the leukemogenic avian erythroblastosis virus AEV (expressing the viral oncogenes v-ErbA and
v-ErbB) and stably expressing the murine erythropoietin
receptor (EpoR)20,21; (4) erythroblasts stably expressing
either the v-ErbA alone22 (these cells share
different aspects of the fully transformed erythroblast phenotype but
both have an extended lifespan); (5) early hematopoietic progenitors
expressing the v-Ski oncogene, capable of undergoing erythroid or
myeloid differentiation depending on the growth factor
combination23; (6) MC29-HD11, a monocytic cell line with
phagocytic capacity24,25; (7) primary chicken embryo
fibroblasts, CEF26; and the avian leghorn male hepatoma cell line, LMH.27
We show that iron metabolism is regulated differently in primary
erythroblasts as compared to several other, constantly proliferating or
transformed cell types. The physiologic demand for high iron uptake
into committed erythroblasts is reflected by exceedingly high levels of
TfR mRNA and protein expression which, in addition, cannot be modulated
by variations in exogenous iron supply. This appears to be due to
stabilization of TfR transcripts and redistribution of iron-loaded
Tf/TfR complexes into intracellular compartments. Neither phenotype was
observed in AEV-transformed erythroleukemic cells or erythroblasts
overexpressing the v-ErbA oncogene alone. This suggests that TfR
hyperexpression is an important feature of committed primary
erythroblasts before the onset of differentiation, which can be
abolished by v-ErbA-mediated leukemic transformation.
Cell culture
Where indicated, iron-saturated chicken transferrin (Tf, 1 mg/mL = 12.5 µM Fe2Tf = 25 µM Fe; the physiologic
concentration in serum, referred to as "high iron"), ferric
ammonium citrate (FAC, 17.5% Fe saturation, 20 µg/mL = 63 µM Fe;
referred to as "iron overload") or desferrioxamine (DFO, 50 µM,
Fe3+-chelator; referred to as "iron deprivation") were
added. Medium containing only the Tf from chS as an iron source is
referred to as "low iron" (0.5-1.1 µM Fe, depending on the serum
concentration in the medium).
Flow cytometry
RNA isolation and Northern blot analysis Total RNA was prepared from 107 to 4 × 107 cells using 4 M guanidinium thiocyanate (GTC) lysis buffer and extraction with acid phenol/chloroform.32 RNA samples (10 µg) were separated in formaldehyde-3-[N-morpholino]-propanesulfonic acid (MOPS)-agarose gels and transferred to nylon membranes (GeneScreen; Du Pont, Wilmington, DE). After UV cross-linking (Stratalinker 2400; Stratagene, La Jolla, CA), transfer was checked by dyeing with methylene blue. Membranes were hybridized with random-primed 32P-labeled probes specific for chicken TfR mRNA (nt1942-2277 cds cloned by reverse transcription-polymerase chain reaction [RT-PCR] according to the published sequence ACX55348)33 and for normalization with a probe specific for 18S ribosomal RNA (rRNA).34 Quantification of the 32P-signals was performed by laser densitometry (Molecular Dynamics, Sunnyvale, CA) of autoradiographs or PhosphoImage analysis (Molecular Dynamics).Electrophoretic mobility shift assay Cytoplasmic extracts were prepared with a buffer containing 0.2% NP-40. Labeled IRE probes were prepared by in vitro transcription of pSPT-Fer (IRE of human ferritin H-chain mRNA)35 in the presence of 32P cytidine-tri-phosphate (CTP; 800 Ci/mM
[2960 × 1010 Bq], NEN/Du Pont, Wilmington,
DE). IRE/IRP binding reactions were carried out with
2 µg protein and 0.5 ng 32P-labeled IRE probes
(specific activity: 1.3 × 109 dpm/µg) by
incubation for 10 minutes at room temperature. After treatment with
RNase T1 (20 U; Roche, Mannheim, Germany) and 5 µg/µL
heparin for 10 minutes each, RNA-protein complexes were separated in
6% nondenaturing polyacrylamide gels. The total amount of IRP1 was
assessed by in vitro reduction with 3% 2-ME prior to the binding
reaction,36 which also served as internal loading control.37
Immunoelectron microscopy Fixation, cryosectioning, and immunolabeling were performed as described.38 Briefly, cells were fixed by adding 16% paraformaldehyde in Pipes buffer (200 mM, pH 7.0) to a cell suspension to obtain a final concentration of 4% paraformaldehyde. Cells were centrifuged at 1000g for 6 minutes. The supernatant was removed and 8% paraformaldehyde carefully layered onto the pellet. After 1 hour, cells were centrifuged at 13 000g for 5 minutes and the pellets stored for 24 hours at 4°C. Pieces of the pellet were infused with 2.1 M sucrose and cryosectioned in an ultramicrotome (Leica, Solms, Germany). Ultrathin sections were immunolabeled with a monoclonal murine antibody against chicken TfR, JS-8,31 and visualized with rabbit antimouse Protein A/gold (10 nm) complex (Biocell, Helsinki, Finland). The samples were viewed in a transmission electron microscope (JEOL1210; JEOL USA, Peabody, MA) at 80 kV.
Viral transformation with AEV abolishes hyperexpression of TfR in primary erythroblasts Expression of TfR on the cell surface was compared among several chicken cell types of erythroid and nonerythroid origin. Cytofluorometry after in vivo labeling with the antichicken TfR antibody JS-831 was performed with primary SCF erythroblasts, AEV-transformed HD3E22 erythroblasts expressing the viral oncogenes v-ErbA and v-ErbB, v-Ski oncogene-expressing hematopoietic progenitors, the monocytic cell line MC29-HD11, the hepatic cell line LMH, and primary CEF fibroblasts (see "Materials and methods"). All cell types were cultured under "low iron" conditions (ie, without additional iron except endogenous avian Fe-Tf contained in the chS of culture media, corresponding to 0.5-1.1 µM Fe; see "Materials and methods"). Under such conditions, TfR expression should be elevated due to limiting iron supply. HD3E22 and the SCF erythroblasts were also incubated in the presence of physiologic concentrations of iron-loaded conalbumin (1 mg/mL Fe2Tf = 25 µM Fe; "high iron"), which, according to the "standard model" of iron homeostasis, should lead to a reduction in TfR levels.Under low iron, fibroblasts and hepatocytes (CEF, LMH) exhibited low
TfR expression levels (12 and 20 fluorescence units, respectively;
Figure 1), whereas
myc-transformed monocytes (MC29-HD11) had intermediate TfR
levels (45 fluorescence units). Multipotent, v-Ski-expressing progenitors, which contain cells of both
the myeloid and erythroid lineage,23 had an average TfR
level of 30 units. Interestingly, the myeloid fraction of
v-Ski progenitors exhibited TfR signals close to background
levels (6 units), whereas the erythroid-committed v-Ski
cells exhibited 90 fluorescence units, indicating an erythroid-specific
elevation of TfR expression.
In the HD3E22 erythroblasts, TfR levels were intermediate to high (45 units) when grown under low iron; however, the presence of high Tf
caused the expected down-regulation of TfR expression (10 units).
Compared with all the previously tested cell types, extremely high
levels of TfR Hyperexpression of TfR mRNA in primary erythroblasts is independent of iron supply Discrepancies between TfR protein and transcript abundance have been described previously. For example, TfR transcripts increased approximately 20-fold due to transcriptional activation and mRNA stabilization in J2E cells induced to partially differentiate by erythropoietin, whereas expression of surface TfR only doubled.39 Similar observations were also made in murine L-cell fibroblasts under different iron concentrations.40 Therefore, we analyzed iron-dependent regulation of TfR mRNA levels in the cell types described above. In particular, we wanted to test whether iron would induce a modulation of TfR mRNA expression also in the apparently nonresponsive SCF erythroblasts.In general, expression of TfR mRNA correlated well with receptor levels
on the cell surface. Primary erythroblasts showed hyperexpression of
TfR mRNA 100 relative units (ru; Figure
2) as compared with fibroblasts (3 ru;
only visible after extended exposures), monocytic (18 ru) or hepatic
(13 ru) cells. Whereas primary erythroblasts transfected with c-Kit or
v-Ski maintained hyperexpression (94 ru and 80 ru,
respectively), the immortalized leukemic HD3E22 cells lost high-level
expression of TfR mRNA under physiologic concentrations of iron-loaded
Tf (1 mg/mL; 14 ru). Under low iron, however, the HD3E22
cells displayed a 4-fold induction of TfR mRNA abundance (54 ru), which
could be ascribed to IRP-dependent stabilization of TfR-mRNA (see below
and data by others10).
To assess the iron-dependent regulation potential of TfR mRNA in the
various cell types in more detail, cells were treated for 24 hours with
either no additional iron source, or 1 mg/mL Tf, or high concentrations
(63 µM Fe) of the inorganic iron source FAC or 50 µM of the
specific iron chelator DFO (Figure 3).
Higher doses of or longer incubation times with FAC or DFO were not
tolerated by the primary erythroblasts. These conditions were used to
test whether the apparent nonresponsiveness of SCF erythroblasts to various concentrations of the physiologic iron donor Tf could be
overcome by more extreme conditions of iron overload or deprivation, or
by a Tf-independent route of iron administration.
As with different Tf concentrations (Figure 1), primary SCF erythroblasts and erythroblasts overexpressing c-Kit exhibited only a very minor increase of TfR mRNA levels (1.5- to 2-fold) under low iron or iron deprivation compared with iron overload (Figure 3). This suggests that these primary erythroid cells maintained TfR hyperexpression independent of the amount or route of iron uptake. Interestingly, the v-myc-transformed monocytic cells also displayed a similarly small modulation of TfR mRNA abundance (1.5-fold). In contrast, under iron deprivation, the erythroleukemic HD3E22 cells increased TfR transcripts approximately 12-fold compared with FAC-induced iron overload. This regulation pattern closely resembled the situation in the liver-derived LMH cells (about 7-fold induction), which can be seen as a prototype for regulation according to the standard model of iron homeostasis. It should be noted that the maximum levels of TfR mRNA attainable in the different cell types were similar (revealed by multiple cross-correlations and direct comparisons between HD3E22 cells and primary erythroblasts; also compare with Figures 2 and 7). Thus, the extent of iron-dependent modulation of TfR mRNA depends both on the cell type and on leukemic transformation within the erythroid lineage. Cell type-specific differences in TfR mRNA abundance correlate only partially with IRP1 activity According to the standard model of iron homeostasis, opposite regulation of Fer and TfR expression, mediated by iron-dependent modulation of IRP mRNA binding activity, leads to a tight surveillance of intracellular iron levels.7 This model, however, falls short in explaining regulation of iron metabolism in specialized cell types such as macrophages, which have to temporarily store iron from phagocytosed erythrocytes for reutilization,41 or committed and terminally differentiating erythroid cells, which need a high capacity for iron uptake (TfR) and utilization for heme synthesis (e-ALAS), simultaneously.10 Therefore, we tested the correlation between IRP1 activity and TfR expression and the corresponding iron-dependent regulatory potential in the cell types described above.First, appropriate assay conditions had to be defined for the chicken
system. As shown previously, IRP1 has similar structural and functional
properties in different species, including chicken.42 However, compared to the well-studied counterparts of human and murine
origin,7 characteristics of chicken IRP2 versus IRP1 were
only recently reported in the literature.22 Therefore, we
determined the amounts and properties of the IRPs in primary SCF
erythroblasts in relation to the well-characterized murine thymidine
kinase deficient L-cell fibroblasts (Ltk
In chicken, IRE/IRP2 complexes could not be observed with the Fer H probe but were detectable at low levels with pSPT-TR34. These IRE/IRP2 complexes (1) migrated similarly to their murine counterparts; (2) were insensitive toward in vitro reduction by 2-ME, a characteristic property of IRP243; and (3) exhibited the same regulatory pattern and similar association kinetics to the IRE probe in both species (data not shown). Due to the apparently low level of IRP2 in the primary chicken erythroblasts (< 5% that of IRP1), however, IRP2 could not be held responsible for the regulation of iron homeostasis and will not be discussed further. Thus, taken together, the human Fer H-chain IRE transcript appeared to be appropriate for testing apparent and total activity of IRP1 in chicken cells. Next, modulation of IRP1 mRNA binding activity by alterations in iron
supply was compared between the erythroid and nonerythroid chicken cell
types described above. To reach equilibrium, all cells were maintained
for 24 hours under the various conditions regarding iron supply. EMSAs
revealed no significant cell type specific differences in total IRP1
levels, as assessed by in vitro reduction with 3% 2-ME (Figure
5). Apparent IRP1 activity, however, showed a distinct, iron-dependent regulation, depending on the cell
type. HD3E22 cells showed a 3.7-fold increase in IRP1 activity under
low iron (only Tf from the chS in the medium) and a 4.6-fold elevation
under complete iron deprivation (DFO), similarly to hepatic cells
(LMH). In contrast, primary SCF and c-Kit erythroblasts exhibited
essentially no difference in IRP1 activity under low versus high iron
(additional exogenous Tf or ferric ammonium citrate). Only after
nonphysiologic iron deprivation with DFO was an intermediate response
observed (2.5- and 3.7-fold elevation, respectively). Interestingly,
this phenotype resembled the regulation in v-Ski progenitors, which contain a significant fraction of erythroid progenitors resembling SCF erythroblasts.23 In contrast,
the v-myc-transformed monocytic cells (MC29-HD11) showed
high IRP1 activity under all conditions, in line with their
iron-independent elevated level of TfR mRNA (Figure 3). This may
explain the discrepancy between the rather high TfR expression level on
the cell surface as compared with the relatively low mRNA abundance in
this cell type (Figures 1 and 2).
The presence or absence of changes in apparent IRP1 activities, induced by high versus low iron in transformed versus primary erythroblasts, respectively, correlated well with the presence or absence of respective iron-dependent changes in the expression levels of TfR mRNA and protein (Figures 1 and 3). To attribute elevated levels of TfR mRNA under iron scarcity to stabilization by IRP1 would of course conform well to the standard model of iron homeostasis. On the other hand, we had observed significant absolute differences in TfR mRNA abundance and protein levels between the erythroid and nonerythroid cell types even under conditions of low iron (Figures 1 and 2). These lineage-specific differences in absolute TfR expression levels were not at all reflected by the corresponding IRP activities. Thus, additional mechanisms besides IRP-dependent stabilization of TfR mRNA must account for the up-regulation of TfR mRNA and protein in primary erythroid cells. Under high iron, TfR mRNA is stable in primary erythroblasts but destabilized in v-ErbA-transformed leukemic cells To assess how an increase of TfR mRNA in SCF erythroblasts could occur essentially independent of IRP, we asked whether the specific endonuclease involved in TfR mRNA degradation44 might be less active or absent in committed erythroid cells, a possibility suggested from data obtained in mouse erythroleukemic (MEL) cells.45 To this purpose, TfR mRNA stability was measured in iron-chase experiments.35,46The SCF erythroblasts as well as HD3E22 cells were preincubated for 24 hours with DFO to induce iron depletion and thus a maximal level of TfR
mRNA. Subsequently, the chelator was washed out and replaced by high
but physiologic concentrations of Tf, which should lead to rapid
turnover of TfR mRNA according to the standard model. This treatment
did not induce any significant alteration of TfR mRNA stability in the
primary erythroblasts (Figure 6), as
expected from previous experiments (Figures 1, 3, and 5). In sharp
contrast, the transformed HD3E22 cells responded with a rapid decline
of TfR mRNA, with a calculated half-life of less than 2 hours, in
agreement with previously published results.35,46 Under
iron deprivation, SCF erythroblasts and HD3E22 cells exhibited equal
levels of TfR mRNA, suggesting that the transcriptional rate of the TfR
gene is similar in both cell types. Thus iron-independent stabilization
of TfR mRNA apparently is an intrinsic property of primary erythroid
cells, lost on leukemogenic viral transformation.
We previously showed that one of the 2 oncogenes of AEV (the transforming agent of HD3E22), v-ErbA, a constitutively active mutated version of thyroid hormone receptor,47 caused a transformation-specific alteration of Fer mRNA translation.22 Thus we determined whether the same oncogene might be responsible for the leukemic phenotype of TfR mRNA regulation. Erythroblasts expressing v-ErbA29 were subjected to the same experimental regime as the HD3E22 cells. Again, iron repletion reduced TfR mRNA half-life to less than 2 hours (Figure 6). Thus v-ErbA alone is indeed able to cause different aspects of a transformation-specific phenotype of iron metabolism. Taken together, these iron-chase experiments demonstrated that the major determinant for constitutive TfR mRNA hyperexpression in primary chicken erythroblasts is a decreased and iron-independent rate of mRNA turnover. This degradation pathway is restored on transformation by AEV, or, more specifically, by one of the targets of the v-ErbA oncogene. Distinct sensing of intracellular iron levels in primary versus transformed erythroblasts: differential localization of transferrin-bound iron Although IRP1 activity and TfR mRNA expression correlated well in SCF and HD3E22 erythroblasts, it remained unclear why IRP activity could not be modulated by iron in the primary erythroblasts. One possible explanation was that in primary erythroblasts a major fraction of intracellular iron might be inaccessible to the cytoplasmic IRP iron sensing system by remaining "hidden" in endosomal vesicles. Given the high-level expression of TfR in primary erythroblasts and in consequence extensive internalization of Tf/TfR complexes this should lead to an expansion of the corresponding pool within the endocytic compartment.To test this hypothesis we localized TfR in primary and AEV-transformed
HD3E22 erythroblasts by electron microscopy. Ultrathin cryosections
were labeled with a rabbit antibody against chicken TfR (JS-8), and TfR
was visualized with a rabbit antimouse Protein A/gold (10 nm) complex.
High-intensity anti-TfR labeling in the primary erythroblasts was
observed on the plasma membrane and in early endosomes (Figure
7). In addition, the cells internalized large amounts of TfR molecules and appeared to transport TfR molecules from proximal to perinuclear compartments. This distribution pattern was completely different in the transformed HD3E22 cells, where anti-TfR gold particles were concentrated on the plasma membrane, including coated pits and vesicles and only rarely detected in early
endosomes. This TfR receptor redistribution toward later endosomal
compartments in primary SCF erythroblasts was previously described for
HD3 erythroblasts during early stages of terminal differentiation.38
These results, together with the low levels of hemoglobin in SCF erythroblasts (L.L. et al, unpublished observations, February, 2001), suggest that in committed primary erythroblasts internalized iron bound to Tf/TfR complexes may reside in endosomes as a kind of temporary intracellular store before differentiation. With the onset of terminal differentiation, internalized iron is targeted specifically to mitochondria,10 where it becomes chelated as heme.
In this report, we demonstrate that TfR is hyperexpressed in committed primary chicken erythroblasts (SCF erythroblasts). This hyperexpression is maintained under high levels of iron supply, contradicting the standard model of iron homeostasis, which involves iron-sensing IRPs as the prime regulators of TfR expression.7 TfR hyperexpression in erythroblasts involves an iron-independent intrinsic stabilization of TfR mRNA. Moreover, a high amount of iron-bearing Tf/TfR complexes in primary erythroblasts appears to elude the cytoplasmic IRP sensory system by residing in endosomal compartments. Transformation of erythroblasts drastically alters the regulation of iron metabolism: TfR hyperexpression is abolished, TfR responsiveness to alterations in iron levels is restored, and TfR protein relocalizes predominantly to the cell membrane. The "standard model" of iron regulation postulates that iron homeostasis is regulated by interaction of the mRNA binding proteins IRP1 and IRP2 with IREs in mRNAs encoding proteins required for efficient iron uptake and utilization. Depending on IRE positioning, IRP binding stabilizes TfR mRNA and confers less efficient translation initiation of Fer and e-ALAS mRNAs. According to a wealth of published evidence, this model holds true for most nonerythroid cell types and, apparently, also for erythroleukemic cells.7,39,48 Primary, committed erythroid progenitors and terminally differentiating erythroblasts, however, require excessive iron for hemoglobin production, thus presenting a paradox to the standard model; high levels of TfR for efficient iron uptake and high levels of e-ALAS for heme biosynthesis must be expressed simultaneously. Indeed, TfR is essential for erythropoiesis; mice lacking TfR49 have a more severe phenotype than hypotransferrinemic (hpx/hpx; mutation in the Tf gene) mice.50 There was some previous in vivo evidence for TfR hyperexpression in late-stage erythroblasts51,52 as well as embryonic erythroblasts.33 This was primarily attributed to cell type-specific transcriptional control.33 In our case, at least loss of TfR hyperexpression in AEV-transformed HD3E22 cells cannot be explained by reduced transcription. Under iron-deprivation conditions, primary SCF progenitors and leukemic HD3E22 cells could reach similarly high TfR mRNA levels, mediated by increased stabilization via IRP1 (Figures 1-3 and 5). This also ruled out that the TfR promoter is a direct target of v-ErbA/v-ErbB signaling but rather demonstrated that hyperexpression of TfR in primary erythroid progenitors must involve additional mechanisms. In primary SCF and c-Kit-erythroblasts, as well as in v-Ski erythroid progenitors (all having a finite lifespan and the potential to undergo complete erythroid maturation19,23), TfR mRNA and protein levels were not, or only slightly, down-modulated by addition of external iron. In contrast, the immortalized HD3E22 erythroblasts, representing very immature leukemic cells, responded to iron scarcity and deprivation according to the standard model, very similar to the hepatic LMH cells. Moreover, iron-dependent changes in TfR mRNA expression and apparent IRP1 activity correlated strongly in all cell types tested. Modulation of IRP1 activity could not explain the variations of absolute TfR mRNA or protein levels in the various cell types. For example, TfR mRNA levels were 40-fold lower in CEF cells than in SCF progenitors, whereas there was only a 2-fold difference in apparent IRP1 activity. A common denominator for all these apparently disparate observations can be found in the differential activity of the specific endonuclease involved in TfR mRNA turnover (Figure 6). Whereas a switch from low iron supply to high Tf induced rapid decay of TfR transcripts in HD3E22 and v-ErbA-expressing cells (half-life about 2 hours, as expected35,40), no mRNA degradation at all occurred in primary SCF erythroblasts, although the protective IRP activity was low (Figure 5). Interestingly, similar observations of increased TfR mRNA stability regardless of iron supply were reported for differentiating murine erythroleukemia cells.45 Taken together, this is a strong indication for the absence or at least massively reduced activity of the responsible regulatory RNAse in cells committed to terminal erythropoiesis. This may also explain why these effects have escaped detection so far. The majority of erythroid cell systems used are immortalized, either virally transformed or derived from leukemias, and have limited differentiation capability. In the primary erythroblasts, IRP activity was hardly influenced by changes in external iron supply, concomitant with very little change in high-level expression of TfR. By contrast, in HD3E22 cells IRP activity was apparently the major regulator of TfR expression. Therefore, the IRP sensory system seemed to be effectively nonfunctional in primary erythroblasts. According to our data, these differences might arise from differential localization of internalized iron (Figure 7; much higher TfR abundance in endosomes of SCF erythroblasts as compared to transformed HD3E22 cells), consistent with previous data on HD3 cells, the parental cell line to HD3E22.38 Interestingly, in the latter cells, a redistribution of Tf/TfR complexes toward the endosomal network occurred on differentiation induction, during which cells started to resemble SCF erythroblasts also in other properties. In early endosomes of HD3 cells the pH is 5.8, whereas late endosomal compartments have a more acidic pH of 5.38,53 The higher pH in early endosomes may be insufficient to efficiently release iron from TfR-bound Tf. This led to the hypothesis that movement of Tf/TfR complexes to more acidic compartments during erythroid differentiation enables a more efficient uptake and utilization of iron.38 In maturing red cells, the hemoglobin content increases drastically. In line with the arguments above, one of the first events of this concerted process is a massive redistribution of Tf/TfR complexes to late endosomal compartments (L.L. et al, manuscript in preparation). This leads to the intriguing hypothesis that temporary accumulation of iron-laden Tf in endosomes may be one of the prerequisites for commitment of erythroid progenitors, just prior the onset of terminal differentiation. Thereby, iron residing in endosomes would be inaccessible to the cytoplasmic IRP system. This in turn would lead to continued hyperexpression of TfRs, despite high extracellular iron supply, by increased stabilization of the TfR mRNA in addition to erythroid cell-specific transcription. The observations described in this paper can be combined into a model
for iron uptake in committed erythroid progenitors (Figure 8). After endocytosis of Tf/TfR
complexes, iron needs to be released from the endosomes. This
apparently involves a specific iron transporter, divalent metal
transporter 1 (DMT1),54-56 which colocalizes with Tf.57 DMT1 only functions at low pH49 and its
mutated version causes hypochromic microcytic anemia in humans, mice,
and rats. Most likely, ferric iron liberated from Tf is reduced to the
more soluble ferrous form.10,58 This conclusion is
strengthened by recent findings that DMT1 can transport only ferrous
iron.59 Subsequently, at least in erythroid cells, iron
may be specifically targeted toward mitochondria, as suggested by
several independent genetic defects causing sideroblastic anemias as
well as in vitro cell systems.10,60-63 For example, in
differentiating erythroblasts, iron continues to flow into mitochondria
even when the synthesis of protoporphyrin IX is
suppressed.62 Therefore, iron released from Tf in
erythroid endosomes may be shunted directly into mitochondria via
protein-protein interactions until it reaches ferrochelatase, which
inserts iron into protoporphyrin IX. This direct transfer of iron was
recently designated as the "Kiss and Run Hypothesis."10
According to this model (Figure 8), iron taken up by committed erythroid progenitors via the Tf/TfR cycle temporarily resides in hypoacidic endosomes, fails to traffic through mitochondria, and, in consequence, eludes the IRP sensory system. This, in turn, would lead to maintenance of hyperexpression of TfR in primary erythroblasts, despite physiologically high iron supply, to meet the extreme demand for iron uptake during terminal erythropoiesis. With the onset of differentiation, iron is released from endosomal Tf/TfR complexes by acidification, specifically targeted into mitochondria, and almost fully incorporated into heme. Again, traffic of iron out of the mitochondria is minimal and IRP stays in the "low iron" mRNA binding conformation. This does not necessarily interfere with the required e-ALAS translation in the primary erythroblasts, however. Because there is a high abundance of TfR mRNA (due to the absence of endonuclease), almost all the available IRP will be associated with IREs in TfR mRNA and not enough will remain to interfere with translation initiation of e-ALAS mRNA. In line with this argument, we have already previously observed a partial derepression of e-ALAS mRNA translation in committed but still undifferentiated SCF progenitors.22 The interpretation above is also consistent with the observations from transformed HD3E22 cells; due to the activity of the regulatory endonuclease there is much less TfR mRNA. So even in the presence of the same IRP activity, the molar ratio between IRP, e-ALAS mRNA, and TfR mRNA will be shifted toward an excess of IRP over the IREs in the transcripts, thus effectively blocking e-ALAS translation. These cell type-specific mechanisms of erythroid iron metabolism may
be a stringent prerequisite for committed erythroblasts, which become
relaxed on leukemic transformation, where iron metabolism reverts to
the "standard mode" of regulation. In primary erythroblasts, mechanisms preventing iron overload may be less important
Submitted February 23, 2001; accepted March 13, 2002.
Supported by grants from the Herzfelder Family Foundation and the Fonds zur Förderung der Wissenschaftlichen Forschung, Austria. L.L. was the recipient of stipends from the University of Vienna and from the Hans and Blanca Moser-Foundation. The authors have reviewed the manuscript and agree with its content.
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Ernst W. Müllner, Institute of Medical Biochemistry, Division of Molecular Biology, Vienna Biocenter; Dr Bohr-Gasse, A-1030 Vienna, Austria; e-mail: em{at}mol.univie.ac.at.
1. Aisen P, Wessling-Resnick M, Leibold EA. Iron metabolism. Curr Opin Chem Biol. 1999;3:200-206[CrossRef][Medline] [Order article via Infotrieve]. 2. Brittenham GM. Disorders of iron metabolism: iron deficiency and overload. In: Hoffman R,Benz EJ,Shattil SJ,Furie B,Cohen HJ, eds. Hematology: Basic Principles and Practice. Vol 29. New York, NY: Churchill Livingstone; 1991:327-349.
3.
Dautry-Varsat A, Ciechanover A, Lodish HF.
pH and the recycling of transferrin during receptor-mediated endocytosis.
Proc Natl Acad Sci U S A.
1983;80:2258-2262 4. Harford JB, Klausner RD. Coordinate post-transcriptional regulation of ferritin and transferrin receptor expression: the role of regulated RNA-protein interaction. Enzyme. 1990;44:28-41[Medline] [Order article via Infotrieve]. 5. Klausner RD, Rouault TA, Harford JB. Regulating the fate of mRNA: the control of cellular iron metabolism. Cell. 1993;72:19-28[CrossRef][Medline] [Order article via Infotrieve].
6.
Melefors O, Hentze MW.
Iron regulatory factor 7. Rouault T, Klausner R. Regulation of iron metabolism in eukaryotes. Curr Top Cell Regul. 1997;35:1-19[Medline] [Order article via Infotrieve]. 8. Cox TC, Bawden MJ, Martin A, May BK. Human erythroid 5-aminolevulinate synthase: promoter analysis and identification of an iron-responsive element in the mRNA. EMBO J. 1991;10:1891-1902[Medline] [Order article via Infotrieve]. 9. Dandekar T, Stripecke R, Gray NK, et al. Identification of a novel iron-responsive element in murine and human erythroid delta-aminolevulinic acid synthase mRNA. EMBO J. 1991;10:1903-1909[Medline] [Order article via Infotrieve].
10.
Ponka P.
Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells.
Blood.
1997;89:1-25 11. Beug H, Metz T, Mullner EW, Hayman MJ. Self renewal and differentiation in primary avian hematopoietic cells: an alternative to mammalian in vitro models? Curr Top Microbiol Immunol. 1996;211:29-39[Medline] [Order article via Infotrieve].
12.
Alitalo R, Partanen J, Pertovaara L, et al.
Increased erythroid potentiating activity/tissue inhibitor of metalloproteinases and jun/fos transcription factor complex characterize tumor promoter-induced megakaryoblastic differentiation of K562 leukemia cells.
Blood.
1990;75:1974-1982
13.
Marks PA, Breslow R, Rifkind RA, Ngo L, Singh R.
Polar/apolar chemical inducers of differentiation of transformed cells: strategies to improve therapeutic potential.
Proc Natl Acad Sci U S A.
1989;86:6358-6362 14. Hayman MJ, Meyer S, Martin F, Steinlein P, Beug H. Self-renewal and differentiation of normal avian erythroid progenitor cells: regulatory roles of the TGF alpha/c-ErbB and SCF/c-kit receptors. Cell. 1993;74:157-169[CrossRef][Medline] [Order article via Infotrieve]. 15. Schroeder C, Gibson L, Nordstrom C, Beug H. The estrogen receptor cooperates with the TGF alpha receptor (c-erbB) in regulation of chicken erythroid progenitor self-renewal. EMBO J. 1993;12:951-960[Medline] [Order article via Infotrieve]. 16. Steinlein P, Wessely O, Meyer S, Deiner EM, Hayman MJ, Beug H. Primary, self-renewing erythroid progenitors develop through activation of both tyrosine kinase and steroid hormone receptors. Curr Biol. 1995;5:191-204[CrossRef][Medline] [Order article via Infotrieve]. 17. Wessely O, Deiner EM, Beug H, von Lindern M. The glucocorticoid receptor is a key regulator of the decision between self-renewal and differentiation in erythroid progenitors. EMBO J. 1997;16:267-280[CrossRef][Medline] [Order article via Infotrieve]. 18. Beug H, Mullner EW, Hayman MJ. Insights into erythroid differentiation obtained from studies on avian erythroblastosis virus. Curr Opin Cell Biol. 1994;6:816-824[CrossRef][Medline] [Order article via Infotrieve]. 19. Wessely O, Bauer A, Quang CT, et al. A novel way to induce erythroid progenitor self renewal: cooperation of c-Kit with the erythropoietin receptor. Biol Chem. 1999;380:187-202[CrossRef][Medline] [Order article via Infotrieve]. 20. Beug H, Hayman MJ, Graf T. Myeloblasts transformed by the avian acute leukemia virus E26 are hormone-dependent for growth and for the expression of a putative myb-containing protein, p135 E26. EMBO J. 1982;1:1069-1073[Medline] [Order article via Infotrieve]. 21. Steinlein P, Deiner E, Leutz A, Beug H. Recombinant murine erythropoietin receptor expressed in avian erythroid progenitors mediates terminal erythroid differentiation in vitro. Growth Factors. 1994;10:1-16[Medline] [Order article via Infotrieve].
22.
Mikulits W, Schranzhofer M, Bauer A, et al.
Impaired ferritin mRNA translation in primary erythroid progenitors: shift to iron-dependent regulation by the v-ErbA oncoprotein.
Blood.
1999;94:4321-4332 23. Beug H, Dahl R, Steinlein P, Meyer S, Deiner EM, Hayman MJ. In vitro growth of factor-dependent multipotential hematopoietic cells is induced by the nuclear oncoprotein v-Ski. Oncogene. 1995;11:59-72[Medline] [Order article via Infotrieve]. 24. Graf T, von Kirchbach A, Beug H. Characterization of the hematopoietic target cells of AEV, MC29 and AMV avian leukemia viruses. Exp Cell Res. 1981;131:331-343[CrossRef][Medline] [Order article via Infotrieve]. 25. Beug H, von Kirchbach A, Doderlein G, Conscience JF, Graf T. Chicken hematopoietic cells transformed by seven strains of defective avian leukemia viruses display three distinct phenotypes of differentiation. Cell. 1979;18:375-390[CrossRef][Medline] [Order article via Infotrieve]. 26. Graf T, Friis RR. Differential expression of transformation in rat and chicken cells infected with an avian sarcoma virus ts mutant. Virology. 1973;56:369-374[CrossRef][Medline] [Order article via Infotrieve].
27.
Kawaguchi T, Nomura K, Hirayama Y, Kitagawa T.
Establishment and characterization of a chicken hepatocellular carcinoma cell line, LMH.
Cancer Res.
1987;47:4460-4464 28. Beug H, Steinlein P, Bartunek P, Hayman MJ. Avian hematopoietic cell culture: in vitro model systems to study oncogenic transformation of hematopoietic cells. Methods Enzymol. 1995;254:41-76[Medline] [Order article via Infotrieve]. 29. Quang CT, Wessely O, Pironin M, Beug H, Ghysdael J. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation. EMBO J. 1997;16:5639-5653[CrossRef][Medline] [Order article via Infotrieve].
30.
Kieslinger M, Woldman I, Moriggl R, et al.
Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation.
Genes Dev.
2000;14:232-244 31. Schmidt JA, Marshall J, Hayman MJ, Ponka P, Beug H. Control of erythroid differentiation: possible role of the transferrin cycle. Cell. 1986;46:41-51[CrossRef][Medline] [Order article via Infotrieve]. 32. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Anal Biochem. 1987;162:156-159[Medline] [Order article via Infotrieve].
33.
Chan LN, Gerhardt EM.
Transferrin receptor gene is hyperexpressed and transcriptionally regulated in differentiating erythroid cells.
J Biol Chem.
1992;267:8254-8259 34. Hedges SB, Moberg KD, Maxson LR. Tetrapod phylogeny inferred from 18S and 28S ribosomal RNA sequences and a review of the evidence for amniote relationships [published erratum appears in Mol Biol Evol 1991 May;8(3):398]. Mol Biol Evol. 1990;7:607-633[Abstract]. 35. Mullner EW, Neupert B, Kuhn LC. A specific mRNA binding factor regulates the iron-dependent stability of cytoplasmic transferrin receptor mRNA. Cell. 1989;58:373-382[CrossRef][Medline] [Order article via Infotrieve].
36.
Hentze MW, Rouault TA, Harford JB, Klausner RD.
Oxidation-reduction and the molecular mechanism of a regulatory RNA-protein interaction.
Science.
1989;244:357-359
37.
Pantopoulos K, Mueller S, Atzberger A, Ansorge W, Stremmel W, Hentze MW.
Differences in the regulation of iron regulatory protein-1 (IRP-1) by extra- and intracellular oxidative stress.
J Biol Chem.
1997;272:9802-9808
38.
Killisch I, Steinlein P, Romisch K, Hollinshead R, Beug H, Griffiths G.
Characterization of early and late endocytic compartments of the transferrin cycle. Transferrin receptor antibody blocks erythroid differentiation by trapping the receptor in the early endosome.
J Cell Sci.
1992;103:211-232
39.
Busfield SJ, Tilbrook PA, Callus BA, Spadaccini A, Kuhn L, Klinken SP.
Complex regulation of transferrin receptors during erythropoietin- induced differentiation of J2E erythroid cells 40. Mullner EW, Kuhn LC. A stem-loop in the 3' untranslated region mediates iron-dependent regulation of transferrin receptor mRNA stability in the cytoplasm. Cell. 1988;53:815-825[CrossRef][Medline] [Order article via Infotrieve].
41.
Moura E, Noordermeer MA, Verhoeven N, Verheul AF, Marx JJ.
Iron release from human monocytes after erythrophagocytosis in vitro: an investigation in normal subjects and hereditary hemochromatosis patients.
Blood.
1998;92:2511-2519
42.
Rothenberger S, Mullner EW, Kuhn LC.
The mRNA-binding protein which controls ferritin and transferrin receptor expression is conserved during evolution.
Nucleic Acids Res.
1990;18:1175-1179 43. Pantopoulos K, Gray NK, Hentze MW. Differential regulation of two related RNA-binding proteins, iron regulatory protein (IRP) and IRPB. RNA. 1995;1:155-163[Abstract]. 44. Binder R, Horowitz JA, Basilion JP, Koeller DM, Klausner RD, Harford JB. Evidence that the pathway of transferrin receptor mRNA degradation involves an endonucleolytic cleavage within the 3' UTR and does not involve poly(A) tail shortening. Embo J. 1994;13:1969-1980[Medline] [Order article via Infotrieve]. 45. Chan RY, Seiser C, Schulman HM, Kuhn LC, Ponka P. Regulation of transferrin receptor mRNA expression. Distinct regulatory features in erythroid cells. Eur J Biochem. 1994;220:683-692[Medline] [Order article via Infotrieve].
46.
Posch M, Sutterluety H, Skern T, Seiser C.
Characterization of the translation-dependent step during iron-regulated decay of transferrin receptor mRNA.
J Biol Chem.
1999;274:16611-16618 47. Bauer A, Mikulits W, Lagger G, Stengl G, Brosch G, Beug H. The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors. EMBO J. 1998;17:4291-4303[CrossRef][Medline] [Order article via Infotrieve]. 48. Ponka P, Beaumont C, Richardson DR. Function and regulation of transferrin and ferritin. Semin Hematol. 1998;35:35-54[Medline] [Order article via Infotrieve]. 49. Levy JE, Jin O, Fujiwara Y, Kuo F, Andrews NC. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat Genet. 1999;21:396-399[CrossRef][Medline] [Order article via Infotrieve].
50.
Trenor CC 3rd, Campagna DR, Sellers VM, Andrews NC, Fleming MD.
The molecular defect in hypotransferrinemic mice.
Blood.
2000;96:1113-1118
51.
Dolznig H, Boulme F, Stangl K, et al.
Establishment of normal, terminally differentiating mouse erythroid progenitors: molecular characterization by cDNA arrays.
FASEB J.
2001;15:1442-1444 52. Papayannopoulou T, Abkowitz J. Biology of erythropoiesis, erythroid differentiation, and maturation. In: Hoffman R,Benz EJ,Shattil SJ,Furie B,Cohen HJ, eds. Hematology: Basic Principles and Practice. Vol 21. New York, NY: Churchill Livingstone; 1991:252-263. 53. Kornfeld S, Mellman I. The biogenesis of lysosomes. Annu Rev Cell Biol. 1989;5:483-525[CrossRef][Medline] [Order article via Infotrieve]. 54. Fleming MD, Trenor CCr, Su MA, et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet. 1997;16:383-386[CrossRef][Medline] [Order article via Infotrieve].
55.
Fleming MD, Romano MA, Su MA, Garrick LM, Garrick MD, Andrews NC.
Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport.
Proc Natl Acad Sci U S A.
1998;95:1148-1153 56. Andrews NC. The iron transporter DMT1. Int J Biochem Cell Biol. 1999;31:991-994[CrossRef][Medline] [Order article via Infotrieve].
57.
Su MA, Trenor CC, Fleming JC, Fleming MD, Andrews NC.
The G185R mutation disrupts function of the iron transporter Nramp2.
Blood.
1998;92:2157-2163 58. Nunez MT, Gaete V, Escobar A. Endocytic vesicles contain a calmodulin-activated Ca2+ pump that mediates the inhibition of acidification by calcium. Biochim Biophys Acta. 1990;1028:21-24[Medline] [Order article via Infotrieve]. 59. Gunshin H, Mackenzie B, Berger UV, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 1997;388:482-488[CrossRef][Medline] [Order article via Infotrieve].
60.
Allikmets R, Raskind WH, Hutchinson A, Schueck ND, Dean M, Koeller DM.
Mutation of a putative mitochondrial iron transporter gene (ABC7) in X-linked sideroblastic anemia and ataxia (XLSA/A).
Hum Mol Genet.
1999;8:743-749 61. Fitzsimons EJ, May A. The molecular basis of the sideroblastic anemias. Curr Opin Hematol. 1996;3:167-172[Medline] [Order article via Infotrieve].
62.
Richardson DR, Ponka P, Vyoral D.
Distribution of iron in reticulocytes after inhibition of heme synthesis with succinylacetone: examination of the intermediates involved in iron metabolism.
Blood.
1996;87:3477-3488 63. Richardson DR, Ponka P. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim Biophys Acta. 1997;1331:1-40[Medline] [Order article via Infotrieve]. 64. Freshney RI. Culture of Animal Cells: A Manual of Basic Technique. 3rd ed. New York, NY: Wiley-Liss; 1994. 65. Sawyers CL, Denny CT, Witte ON. Leukemia and the disruption of normal hematopoiesis. Cell. 1991;64:337-350[CrossRef][Medline] [Order article via Infotrieve]. 66. Kispal G, Csere P, Prohl C, Lill R. The mitochondrial proteins Atm1p and Nfs1p are essential for biogenesis of cytosolic Fe/S proteins. EMBO J. 1999;18:3981-3989[CrossRef][Medline] [Order article via Infotrieve]. 67. Csere P, Lill R, Kispal G. Identification of a human mitochondrial ABC transporter, the functional orthologue of yeast Atm1p. FEBS Lett. 1998;441:266-270[CrossRef][Medline] [Order article via Infotrieve]. 68. Shirihai OS, Gregory T, Yu C, Orkin SH, Weiss MJ. ABC-me: a novel mitochondrial transporter induced by GATA-1 during erythroid differentiation. EBMO J. 2000;19:2492-2502[CrossRef][Medline] [Order article via Infotrieve].
© 2002 by The American Society of Hematology.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
 |
|
  M. Schranzhofer, M. Schifrer, J. A. Cabrera, S. Kopp, P. Chiba, H. Beug, and E. W. Mullner Remodeling the regulation of iron metabolism during erythroid differentiation to ensure efficient heme biosynthesis Blood, May 15, 2006; 107(10): 4159 - 4167. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|||||||
 |
 |
 |
 |
 |
 |
 |
 |
||
| Copyright © 2002 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||
Top
Abstract
Introduction
-aminolevulinic acid
synthase (e-ALAS),
fibroblasts received
DMEM plus 10% FCS.
Tf). The
erythroleukemic HD3E22 cells and the primary erythroid SCF progenitors
were cultured either under physiologic iron supply (1 mg/mL Tf; for
details see "Materials and methods"; labeled +Tf), or without
additional iron source (
here referred to as "hyperexpression"
